Falciformopexy for Treatment Perforated Peptic Ulcer.
1 other identifier
interventional
25
0 countries
N/A
Brief Summary
Use the falciform ligament flap for the treatment of perforated peptic ulcer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2022
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedStudy Start
First participant enrolled
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 23, 2026
March 10, 2023
March 1, 2023
3.4 years
September 29, 2022
March 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Falciformopexy for Treatment Perforated Peptic Ulcer
The aim is to decrease incidence of leakage from the perforated peptic ulcer by using the falciform ligament for repair of the perforated peptic ulcer. Firstly, the investigator will seek to repair the perforation using suture to approximate edges then use falciform ligament as a secound layer to ensure security and prevent postoperative leakage that will lead to peritonitis and death.
Baseline
Study Arms (1)
Falciformopexy for Treatment Perforated Peptic Ulcer
OTHERUse falciform ligament flap for repair perforated peptic ulcer
Interventions
use the falciform ligament on perforated peptic ulcer
Eligibility Criteria
You may qualify if:
- \- Any cases presented with PPU within age from 18 till 70 years.
You may not qualify if:
- malignancy.
- Previous GIT and liver surgery.
- nonoperative treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Fry DE, Richardson JD, Flint LM Jr. Closure of an acute perforated peptic ulcer with the falciform ligament. Arch Surg. 1978 Oct;113(10):1209-10. doi: 10.1001/archsurg.1978.01370220095016.
PMID: 708243BACKGROUNDSon TQ, Hoc TH, Huong TT, Long VD, Tung TT, Quyet NC, Panha L, Van Chi N. Outcomes of surgical management of peptic ulcer perforation using the falciform ligament: A cross-sectional study at a single centre in Vietnam. Ann Med Surg (Lond). 2021 Jun 16;67:102477. doi: 10.1016/j.amsu.2021.102477. eCollection 2021 Jul.
PMID: 34188907BACKGROUNDSung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009 May 1;29(9):938-46. doi: 10.1111/j.1365-2036.2009.03960.x.
PMID: 19220208BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Doaa Hamada Abd elbaset
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 29, 2022
First Posted
February 8, 2023
Study Start
May 30, 2023
Primary Completion (Estimated)
October 23, 2026
Study Completion (Estimated)
November 23, 2026
Last Updated
March 10, 2023
Record last verified: 2023-03